BioArctic AB (FRA:B9A) Total Noninterest Expense

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:B9A BioArctic AB FRA:B9A
77 GF Score
Price €29.24
GF Value €43.46
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is BioArctic AB Total Noninterest Expense?

Total Noninterest Expense only applies to banks.

FRA:B9A
77GF Score
BioArctic AB FRA:B9A
Total Noninterest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioArctic AB (FRA:B9A) Overvalued in 2026?

Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued. The current stock price of €29.24 is trading 32.7% below its estimated GF Value™ of €43.46. GuruFocus considers BioArctic AB to be Possible Value Trap.

Key valuation signals for FRA:B9A:

  • Total Noninterest Expense:
  • GF Value™: €43.46 vs. price of €29.24 (32.7% below fair value)
  • GF Score™: 77/100 with 8 warning signs

No single metric tells the full story. See the FRA:B9A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
77GF Score

Get the complete analysis for FRA:B9A

Total Noninterest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€29.24
Price
€43.46
GF Value